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Abstract
Cohort studies, randomized trials, and post-licensure studies have reported reduced natural
and vaccine-derived protection against rotavirus gastroenteritis (RVGE) in low- and middle-
income countries. While susceptibility of children to rotavirus is known to vary within and
between settings, implications for estimation of immune protection are not well understood.
We sought to re-estimate naturally-acquired protection against rotavirus infection and
RVGE, and to understand how differences in susceptibility among children impacted esti-
mates. We re-analyzed data from studies conducted in Mexico City, Mexico and Vellore,
India. Cumulatively, 573 rotavirus-unvaccinated children experienced 1418 rotavirus infec-
tions and 371 episodes of RVGE over 17,636 child-months. We developed a model that
characterized susceptibility to rotavirus infection and RVGE among children, accounting for
aspects of the natural history of rotavirus and differences in transmission rates between set-
tings. We tested whether model-generated susceptibility measurements were associated
with demographic and anthropometric factors, and with the severity of RVGE symptoms.
We identified greater variation in susceptibility to rotavirus infection and RVGE in Vellore
than in Mexico City. In both cohorts, susceptibility to rotavirus infection and RVGE were
associated with male sex, lower birth weight, lower maternal education, and having fewer
siblings; within Vellore, susceptibility was also associated with lower socioeconomic status.
Children who were more susceptible to rotavirus also experienced higher rates of rotavirus-
negative diarrhea, and higher risk of moderate-to-severe symptoms when experiencing
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1007014 July 26, 2019 1 / 23
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Lewnard JA, Lopman BA, Parashar UD,
Bennett A, Bar-Zeev N, Cunliffe NA, et al. (2019)
Heterogeneous susceptibility to rotavirus infection
and gastroenteritis in two birth cohort studies:
Parameter estimation and epidemiological
implications. PLoS Comput Biol 15(7): e1007014.
https://doi.org/10.1371/journal.pcbi.1007014
Editor: Cecile Viboud, National Institutes of Health,
UNITED STATES
Received: January 2, 2018
Accepted: April 9, 2019
Published: July 26, 2019
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced,
distributed, transmitted, modified, built upon, or
otherwise used by anyone for any lawful purpose.
The work is made available under the Creative
Commons CC0 public domain dedication.
Data Availability Statement: Age and symptoms
at each rotavirus infection for the two cohorts are
attached as supplemental files; these constitute the
basis for model fitting. Additional data on
covariates (risk factors, anthropometrics,
socioeconomic variables) cannot be shared
publicly due to identifiability concerns. Datasets are
available from the institutional review boards of
Christian Medical College (contact via
research@cmcvellore.ac.in) and of the Instituto
Nacional de Ciences Me´dicas y Nutricio´n Salvador
RVGE. Simulations suggested that discrepant estimates of naturally-acquired immunity
against RVGE can be attributed, in part, to between-setting differences in susceptibility of
children, but result primarily from the interaction of transmission rates with age-dependent
risk for infections to cause RVGE. We found that more children in Vellore than in Mexico
City belong to a high-risk group for rotavirus infection and RVGE, and demonstrate that
unmeasured individual- and age-dependent susceptibility may influence estimates of natu-
rally-acquired immune protection against RVGE.
Author summary
Differences in susceptibility can help explain why some individuals, and not others,
acquire infection and exhibit symptoms when exposed to infectious disease agents. How-
ever, it is difficult to distinguish between differences in susceptibility versus exposure in
epidemiological studies. We developed a modeling approach to distinguish transmission
intensity and susceptibility in data from cohort studies of rotavirus infection among chil-
dren in Mexico City, Mexico, and Vellore, India, and evaluated how these factors may
have contributed to differences in estimates of naturally-acquired immune protection
between the studies. Given the same exposure, more children were at high risk of acquir-
ing rotavirus infection, and of experiencing gastroenteritis when infected, in Vellore than
in Mexico City. The probability of belonging to this high-risk stratum was associated with
well-known individual factors such as lower socioeconomic status, lower birth weight,
and incidence of diarrhea due to other causes. We also found the risk for rotavirus infec-
tions to cause symptoms declined with age, independent of acquired immunity. These
findings can, in part, account for estimates of lower protective efficacy of acquired immu-
nity against rotavirus gastroenteritis in high-incidence settings, mirroring estimates of
reduced effectiveness of live oral rotavirus vaccines in low- and middle-income countries.
Introduction
Rotavirus is the leading source of gastrointestinal disease burden in children globally, with
nearly 10 million severe cases and 193,000 fatalities estimated to occur annually [1]. One
decade after their rollout in high-income settings, live oral rotavirus vaccines are currently
being introduced to national immunization programs of low- and middle-income countries
(LMICs). However, randomized controlled trials and post-licensure studies have reported
lower vaccine efficacy and effectiveness against rotavirus gastroenteritis (RVGE) in LMICs
compared to higher-income settings [2,3]. Understanding this performance gap is essential to
maximizing the impact of rotavirus vaccines where they are needed most.
Recent observational studies have investigated how factors such as oral polio vaccine co-
administration [4,5], exposure to breast milk antibodies [6], environmental enteropathy [7],
and nutritional status [8,9] influence susceptibility of children to RVGE and performance of
oral vaccines. Variation in susceptibility among individuals within and between studies—due
to these or other unmeasured risk factors—is well known to influence estimates of vaccine effi-
cacy and effectiveness [10–13]. Differential removal of highly-susceptible individuals to a par-
tially-immune state constitutes a form of frailty bias or effect modification that may persist
even in randomized studies [10,14,15]; we use the term bias here in reference to discrepancies
between common measures of association, such as hazard ratios and risk ratios, and the per-
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exposure biological effect of immunity (from vaccination or natural infection) on infection
and/or disease endpoints [16,17]. Demonstrations of the impact of variation in susceptibility
have arisen in both experimental and theoretical studies [18,19]. Refinements in our ability to
characterize such variation both statistically and experimentally [20–27], together with formal-
izations of per-exposure measures of intervention efficacy in trials [28–30] and observational
studies [16,17], have highlighted the potential for heterogeneity in susceptibility to influence
epidemiologic measurements.
While the possibility of such frailty bias in rotavirus vaccine studies has been raised
[15,31,32], distinguishing its contribution to variation in estimates of vaccine protection
against RVGE has been difficult given the concordance of observed patterns with multiple
hypotheses [33]. Importantly, the rate of asymptomatic infections and the distribution of risk
factors across settings are not easily measured or compared [34], and individual variation in
susceptibility may be only partially attributable to known or measured risk factors.
Similarly-designed birth cohort studies undertaken in socioeconomically-distinct LMIC
populations of Mexico City, Mexico and Vellore, India provide an opportunity to characterize
heterogeneity in susceptibility to rotavirus infection and RVGE, and to assess its influence on
estimates of immune protection [35,36]. While the two studies supplied similar estimates of
naturally-acquired immune protection against re-infection, differences in estimates of protec-
tion against RVGE reflected discrepancies in estimated vaccine efficacy between Latin America
and South Asia [37–39]. Whereas no children in Mexico City experienced moderate-to-severe
RVGE after two or more previous infections, two previous infections were associated with
only 57% protection against moderate-to-severe RVGE among children in Vellore [35,36].
Paired re-analysis of the studies has provided evidence that differences owe, in part, to the
influence of a subset of “high-risk” individuals in the Vellore cohort—who experienced high
rates of rotavirus infection as well as high risk for RVGE given infection—and age-dependent
risk for RVGE given infection [33].
We revisited data from these studies aiming to better understand and compare the distribu-
tion of susceptibility among individuals within the two cohorts, and to explore the implications
for epidemiologic analyses. We developed a model to estimate susceptibility of children to
rotavirus infection and RVGE, accounting for the natural history of rotavirus and differences
between settings in transmission intensity. We conducted statistical inference via kernel-based
and Markov chain Monte Carlo inference approaches, recovering near-identical parameter
estimates under the two strategies. We used our findings to explore the influence of sources of
bias underlying conventional measures of protective immunity.
Results
Cohort monitoring
Incidence of rotavirus infection and RVGE among children enrolled in the two cohorts has
been described previously [33,35,36,40]. Briefly, the studies enrolled 200 and 373 unvaccinated
Mexican and Indian children who were followed from birth to up to 2 years and 3 years of age,
respectively, yielding 3699 and 13,937 child-months of follow-up, and characterized the spec-
trum of asymptomatic to severe clinical manifestations of each rotavirus infection. In total,
315 rotavirus infections were detected in Mexico City and 1103 were detected in Vellore, with
89 (28% of 315 infections) and 282 (26% of 1103 infections) episodes of RVGE occurring in
the two settings, respectively. Incidence was higher in Vellore, such that first infections
occurred in 56% and 81% of Indian children by ages 6 months and one year, compared to 34%
and 67% of Mexican children, respectively (Fig 1A and 1B).
Heterogeneous susceptibility to rotavirus
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The proportion of infections causing RVGE declined with a higher number of previous
infections (Fig 1C and 1D). However, analyses stratified by age and previous infection
revealed this trend could owe to confounding by age, i.e. declining RVGE risk with older age
for each of first, second, and later infections (Fig 1E and 1F). At matched ages, RVGE was
more common, paradoxically, during second and later infections than first infections in Vel-
lore. In contrast, this trend was not apparent in Mexico City.
Rotavirus natural history
We developed a set of model structures addressing biological hypotheses of rotavirus natural
history, based on previous studies of transmission dynamics [41–43] and secondary analysis of
the birth-cohort datasets [33]. We estimated the proportion of each cohort belonging to a
“high-risk” group, and tested for evidence of variation in susceptibility to infection and/or risk
of RVGE given infection among the high-risk group compared to the rest of the cohort (see
Materials and Methods). We also tested whether the risk of RVGE given infection varied
depending on age at time of infection, and/or the number of previous infections.
Fig 1. Natural history of rotavirus infection: Observations and model predictions. We plot cumulative incidence of first, second, third, and fourth rotavirus
infections by age within the (A) Mexico City and (B) Vellore cohorts; shaded areas define 95% prediction intervals as fitted by the model, accounting for variation in risk
among children and loss to follow-up, with dotted lines indicating median model predictions. (C and D) Observed proportions (circles, with 95% credible intervals) of
infections involving RVGE, and model-predicted probabilities of RVGE given infection (triangles, with 95% prediction intervals), are plotted side by side. (E and F) We
plot age-specific proportions of primary, secondary, third, and later infections involving RVGE (with 95% credible intervals); age strata within which such proportions
are calculated correspond to the interval for serological sampling within the two cohorts (four months in Mexico City; six months in Vellore); these age bins are
illustrated in the lower half of the x-axis. We superimpose these age-stratified estimates against the continuous decline in risk for infections to cause RVGE estimated by
our fitted model (shaded peach); the lower estimate corresponds to the population of a low-risk sub-group (R), while the higher estimate corresponds to a higher-risk
subgroup (RC) whose risk for RVGE, given infection, is increased by a factor ρ (Table 1). The intermediate region (shaded orange) denotes risk for the average child
within the cohorts. Shaded areas denote 95% prediction intervals around estimates of age-specific risk.
https://doi.org/10.1371/journal.pcbi.1007014.g001
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We estimated 33% (95% CI: 23% to 41%), 50% (42% to 57%), and 64% (55% to 70%) reduc-
tions in the rates at which children re-acquired rotavirus after one, two, or three or more previ-
ous infections (Table 1), closely recapitulating estimated protection against re-infection in the
original studies (S2 Table) [35,36].
Our models also captured declining risk for infections to cause symptomatic RVGE at older
ages (Fig 1B). The proportion of secondary and subsequent infections causing RVGE in the
first year of life in Vellore closely matched expectations among children classified as a “high-
risk” subset of the population (detailed below; Fig 1F). We compared the fit of models with dif-
fering assumptions about acquired immune protection against RVGE given infection
(Table 1). After accounting for declining risk of RVGE given infection at older ages, we did
not identify improvements in fit (based on values of the Akaike Information Criterion [44])
when allowing for acquired immune protection against symptoms during second or later
infections (Model 2).
Several salient differences between the two studies were reproduced in model-based predic-
tions. Although we predicted higher-than-observed rates of infection in Mexico City during
the first six months of life, predictions accurately reflected between-setting differences in
cumulative incidence by the end of the first year (Fig 1A and 1B). In addition, fitted parame-
ters recapitulated the observation of significantly lower probabilities of RVGE during second,
third, and fourth infections in Mexico City as compared to Vellore (Fig 1C and 1D), despite
predicting RVGE in a higher-than-observed proportion of second infections in Mexico City.
Table 1. Parameter estimates and AIC values from models.
Measure Definition Estimate (95% CI)
Model 12 Model 22
α Mexico City (M) Proportion of population belonging to R subgroup 0.03 (0.01, 0.38) 0.04 (0.01, 0.46)
Vellore (V) 0.15 (0.06, 0.39) 0.17 (0.07, 0.49)
P(αM>αV) Test for difference between cohorts in prevalence of R subgroup (p value) p = 0.0594 p = 0.0822
ϕ Hazard ratio for infection in R subgroup 1.74 (1.27, 2.46) 1.63 (1.15, 2.37)
ρ Relative risk for diarrhea (given infection) in R subgroup 2.39 (1.91, 3.14) 2.24 (1.69, 3.12)
β0 Intercept term, function for RVGE risk given age -1.05 (-1.31, -0.81) -1.24 (-1.66, -0.84)
β1 Linear term, function for RVGE risk given age
1 -0.16 (-0.52, 0.20) -0.33 (-0.80, 0.13)
β2 Quadratic term, function for RVGE risk given age
1 -0.54 (-1.06, -0.02) -0.42 (-0.99, 0.14)
Λ Mexico City (M) Force of infection (baseline infection rate per child per year in the Rc group) 2.27 (1.54, 3.31) 2.11 (1.42, 3.19)
Vellore (V) 2.55 (1.82, 3.69) 2.37 (1.67, 3.54)
P(ΛM>ΛV) Test for difference in force of infection (p value) p = 0.0496 p = 0.0490
ψk k = 0 Hazard ratio for infection given previous exposure 1.00 (ref.) 1.00 (ref.)
k = 1 0.67 (0.59, 0.77) 0.67 (0.59, 0.77)
k = 2 0.50 (0.43, 0.58) 0.50 (0.43, 0.58)
k� 3 0.36 (0.30, 0.45) 0.37 (0.30, 0.46)
ωk k = 0 Relative risk for RVGE during infection given previous exposure 1.00 (fixed) 1.00 (ref.)
k = 1 - - 1.14 (0.91, 1.44)
k = 2 - - 1.15 (0.80, 1.64)
k� 3 - - 1.30 (0.83, 2.07)
AIC Akaike information criterion (penalized measure of model fit) 21000.52 21005.38
e–ΔAIC/2 Relative model likelihood (AIC-penalized) 1 0.088
1Linear and quadratic age inputs are centered and scaled to unit variance in the original model.
2Model 2 estimates the effect of acquired immune from previous infections on risk of symptoms given reinfection (ωk) controlling for age at infection; Model 1 assumes
that the risk of RVGE given infection only depends on age at infection. A third model—wherein such an effect was limited to the RC risk group—was not identifiable.
https://doi.org/10.1371/journal.pcbi.1007014.t001
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Variation in susceptibility among children
Our modeling framework partitioned the cohort populations across distinct risk groups (R
and RC) with prevalences αM and 1–αM, respectively, in Mexico City, and αV and 1–αV in Vel-
lore. Because the size of the risk group and group-specific relative risk for infection and/or dis-
ease outcomes are inversely related, the relative susceptibility and prevalence of these two risk
groups were not simultaneously identifiable. We therefore estimated conditional between-
group differences in susceptibility to infection (hazard ratio ϕ) and RVGE given infection (rel-
ative risk ρ) associated with particular values of αM and αV. We reconstructed the full distribu-
tion of ϕ and ρ from the marginal distributions of {ϕ,ρ}|{αM,αV} (see Materials and Methods).
Fitting a more complex model (S1 Text) which considered an exhaustive set of risk groups—
including children with modified susceptibility to infection only or disease only—allowed us
to verify the hypothesis of a linkage between children’s susceptibility to infection and disease
given infection, which was suggested in previous analyses of the cohort data [33].
This modeling approach enabled us to compare the prevalence of children with particular
susceptibility levels between cohorts (Fig 2). We estimated that 3% (1% to 23%) of children in
Mexico City would belong to a high-risk-stratum experiencing a�50% higher-than-baseline
rate of acquiring rotavirus infection, compared to 13% (6% to 29%) of children in Vellore (Fig
2G). A subgroup with over double the baseline rate of infection would include 2% (1% to 8%)
of children in Mexico City and 10% (5% to 18%) of children in Vellore, while only 1% (0% to
2%) of children in Mexico City and 6% (5% to 9%) of children in Vellore would belong to a
subgroup experiencing rates of infection�3-fold higher than the baseline rate. Greater suscep-
tibility to infection was associated with higher risk of experiencing RVGE given infection,
regardless of the prevalence of the high-risk group (Fig 2F); fitting both ϕ and ρ, we identified
�99.99% probability for excess risk of disease given infection within the sub-cohorts defined
to have higher rates of acquiring infection (S1 Table). Joint distributions of ϕ and ρ with the
size of the risk groups were indistinguishable under the original model specification and a
more complex model that allowed either linked or unlinked susceptibility to infection and dis-
ease (S1 Text, S2 Fig).
Determinants of susceptibility among individual children
Our modeling approach provided a statistical basis for calculating the probability that each
child belonged to the “high-risk” subgroup (see Materials and Methods). To examine the valid-
ity of these estimates, we next assessed whether a child’s estimated risk of belonging to the
“high-risk” subgroup was related to host factors and exposures measured in the original stud-
ies that have previously been reported to predict risk for rotavirus infection and RVGE (Tables
2 and 3).
Male children were 26% (4% to 67%) more likely to be among the “high-risk” subgroup
than female children (Table 3). Birth weight was also a predictor of being in the “high-risk”
subgroup, with each log-kilogram decrease in birth weight conferring 2.05 (1.02 to 5.03)-fold
higher probability of belonging to the “high-risk” subgroup. However, we did not detect a sig-
nificant association between susceptibility and weight at 12 months. In each cohort as well as
in the pooled analysis, children without siblings were more likely to belong to the “high-risk”
subgroup than children with siblings. In comparison to children whose mothers had com-
pleted<5 years of education, children whose mothers had completed�10 years of education
were 25% (0% to 50%) less likely to belong to the “high-risk” subgroup.
We also identified several factors predicting within-cohort variation in susceptibility that
were consistent with findings in primary analyses of the studies [35,36]. In Vellore, children
whose household members were involved in producing bidis (indigenous cigarettes)—an
Heterogeneous susceptibility to rotavirus
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indicator of lower household socioeconomic status—were 45% (10% to 122%) more likely
than other children to belong to the “high-risk” subgroup. In Mexico City, children with a
shorter duration of breastfeeding were more likely to belong to the “high-risk” subgroup,
although this association did not reach conventional thresholds of statistical significance in
our analysis.
Among children experiencing RVGE in the cohorts, those who experienced moderate-to-
severe RVGE symptoms (defined by a Vesikari score�11) on at least one episode were 44%
(13% to 122%) more likely to belong to the “high-risk” subgroup, suggesting model-based
measures of susceptibility to rotavirus infection and (any) RVGE given infection also predicted
the severity of rotavirus disease. In addition, children who experienced higher rates of diar-
rheal episodes caused by pathogens other than rotavirus were more likely to belong to the
Fig 2. Heterogeneity in susceptibility to rotavirus infection and RVGE within and between cohorts. We plot estimates of (A) the relative prevalence of thge “high-
risk” subgroup within Vellore (αV) versus Mexico City (αM). For the high-risk subgroup within each cohort, we illustrate (B) subgroup-specific hazard ratio of infection
(ϕ) and (C) relative risk of RVGE given infection (ρ). (D) Sampled points (blue) illustrate the likelihood surface of the joint prevalence of subgroups within the Vellore
and Mexico City cohorts; underlying isoclines illustrate the uneven likelihood surface on a natural log scale, while the preponderance of points above the red diagonal
suggests that the high-risk subgroup is more prevalent in Vellore than in Mexico City (as indicated in A). Near-identical results arise under a model that allows either
linked or unlinked susceptibility to infection and disease (S1 Text; S2 Fig, panel E). We next illustrate (E) estimates of the absolute sizes of the high-risk subgroups in
Vellore (green) and Mexico City (yellow). Sampling from the joint distributions of αV, αM, ϕ, and ρ, (F) we generate simulated cohorts of children from Mexico City
(orange points) and Vellore (green) to illustrate their relative susceptibility to infection and to RVGE, given infection. We next illustrate (G) the probability of “high-
risk” status among children in Mexico City and Vellore associated with increasing values of ϕ, the hazard ratio of infection among those who belong to the “high-risk”
group. The estimated probability of belonging to the “high-risk” group declines as the group is defined by a more-pronounced risk differential. Similarly, we illustrate
(H) the declining probability of belonging to the “high-risk” group under increasing values of ρ, the relative risk of RVGE given infection among high-risk children.
https://doi.org/10.1371/journal.pcbi.1007014.g002
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“high-risk” subgroup within each cohort. In Vellore, we also found a positive association
between the incidence of acute respiratory infections and the likelihood that a child belonged
to the “high-risk” subgroup; this information was not available for the Mexico City cohort.
Sources of variation in estimates of naturally-acquired immune protection
We next conducted simulation studies (Fig 3) to assess how variation in transmission intensity
and in the susceptibility of children could influence estimates of naturally-acquired immune
protection against rotavirus infection, RVGE, and RVGE given infection [45]—as measured
by the hazard ratios of infection and RVGE, and relative risk of RVGE given infection—fol-
lowing one, two, or three previous infections, compared to zero previous infections. We com-
pared estimates from in silico cohorts with differing prevalence of “high-risk” children (α)
Table 2. Characteristics of the two cohorts.
Observation Mexico City Vellore
Birth weight (kg) 3.2 (median; IQR: 2.9, 3.4) 3.0 (median; IQR: 2.7, 3.2)
Weight at 12 mo. (kg) 10.0 (median; IQR: 9.1, 10.6) 7.9 (median; IQR: 7.3, 8.6)
Sex Female 94 (47.0%) 186 (49.9%)
Male 106 (53.0%) 187 (50.1%)
Duration of breastfeeding1
<3 months 59 (38.1%) 15 (4.1%)
3–5 months 27 (17.4%) 27 (7.3%)
6–11 months 31 (20.0%) 56 (15.1%)
12+ months 38 (24.5%) 272 (73.5%)
Number of siblings
0 66 (33.8%) 118 (31.6%)
1 56 (28.7%) 123 (33.0%)
2 38 (19.5%) 90 (24.1%)
3+ 35 (17.9%) 42 (11.3%)
Socioeconomic status
Lowest 24 (12.3%) – –
Intermediate 81 (41.5%) – –
Highest 90 (46.2%) – –
Not bidi-working household – – 200 (53.6%)
Bidi-working household – – 173 (46.4%)
Maternal education2
0–4 years 57 (29.2%) 106 (28.4%)
5–7 years 62 (31.8%) 109 (29.2%)
8–9 years 46 (23.6%) 90 (24.1%)
�10 years 30 (15.4%) 68 (18.2%)
RVGE and symptom severity Children experiencing any RVGE episode(s) 77 (38.5%) 178 (47.7%)
Children experiencing RVGE with Vesikari score�11 14 (7.0%) 58 (15.5%)
Episodes of rotavirus-negative diarrhea3 4 (median; IQR: 2, 7) 4 (median; IQR: 2, 6)
Episodes of respiratory infection – – 20 (median; IQR: 14, 26)
All percentages are calculated among children from whom data were available for the given variable. IQR: interquartile range.
1Calculated among children retained for over 1 year in the study.
2Breakpoints for the years of maternal education were defined according to the following standard for Vellore: 0–4, no formal education or primary school incomplete;
5–7, primary school complete; 8–9, middle school complete; 10 or more, high school complete.
3Duration of follow-up differs by setting (up to 2 years in Mexico City, versus up to 3 years in Vellore).
https://doi.org/10.1371/journal.pcbi.1007014.t002
Heterogeneous susceptibility to rotavirus
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1007014 July 26, 2019 8 / 23
exposed to varying forces of infection (Λ). We accounted for susceptibility differences between
risk groups by sampling from the joint, unconditional distribution of {ϕ,ρ}, thereby isolating
the effect of differences in risk-group prevalence.
Table 3. Factors associated with belonging to the “high-risk” group.
Risk factor Relative Risk (95% CrI)
Mexico City Vellore Pooled analysis
Birth weight per log kg 0.68 (0.42,
0.94)
0.84 (0.58, 1.13) 0.47 (0.20,
0.98)
Weight at 12 mo. per log kg 0.88 (0.74,
1.01)
1.00 (0.85, 1.16) 0.68 (0.23,
1.66)
Sex Female ref. ref. ref.
Male 1.05 (0.79,
1.42)
1.38 (1.08, 2.03) 1.26 (1.04,
1.67)
Duration of breastfeeding1
<3 months ref. ref. ref.
3–5 months 0.69 (0.41,
1.07)
1.12 (0.434,
3.04)
0.79 (0.50,
1.20)
6–11 months 0.91 (0.54,
1.44)
1.16 (0.480,
2.86)
0.91 (0.59,
1.37)
12+ months 0.70 (0.42,
1.05)
1.11 (0.485,
2.51)
0.83 (0.54,
1.17)
Number of siblings
0 ref. ref.
1 0.88 (0.59,
1.27)
0.72 (0.455,
0.98)
0.76 (0.52,
0.97)
2 0.69 (0.42,
0.98)
0.79 (0.509,
1.16)
0.75 (0.53,
1.00)
3+ 0.49 (0.28,
0.74)
0.74 (0.413,
1.12)
0.61 (0.40,
0.83)
Socioeconomic status
Lowest ref. – – – –
Intermediate 1.20 (0.78,
1.92)
– – – –
Highest 1.17 (0.77,
1.78)
– – – –
Not bidi-working household – – ref. – –
Bidi-working household – – 1.45 (1.095,
2.22)
– –
Maternal education
0–4 years (primary school incomplete) ref. ref. ref.
5–7 years (primary school complete) 1.21 (0.86,
1.80)
0.89 (0.62, 1.28) 0.99 (0.76,
1.32)
8–9 years (middle school complete) 1.14 (0.77,
1.76)
0.90 (0.61, 1.35) 0.98 (0.73,
1.34)
�10 years (high school complete) 1.13 (0.75,
1.80)
0.62 (0.36, 0.90) 0.75 (0.50,
1.00)
Severity of RVGE episodes Any episode with Vesikari score�11 (among children experiencing
RVGE)
1.17 (0.82,
1.97)
1.52 (1.13, 2.55) 1.44 (1.13,
2.22)
Incidence of rotavirus-negative
diarrhea
per log episodes/year 1.07 (1.02,
1.16)
1.38 (1.17, 1.72) 1.15 (1.07,
1.28)
Incidence of respiratory infections per log episodes/year – – 1.13 (1.10, 1.19) – –
1Only children retained in studies for over 1 year are included in analyses.
https://doi.org/10.1371/journal.pcbi.1007014.t003
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We did not identify a large of impact of susceptibility differences on estimates of protection
against reinfection (i.e. estimates of N^E were similar across different levels of Λ and α), which
may help to explain why these estimates were nearly equal in the original studies [35,36]. How-
ever, we found that estimates of protection against RVGE—which were lower in primary anal-
yses of the Vellore cohort—were expected to decline in settings with higher transmission
intensity, reflecting acquisition of infection at younger, higher-risk ages. The impacts of het-
erogeneity in susceptibility were outweighed by the impacts of unaccounted-for age-depen-
dent symptom risk. For a population exposed to transmission intensity on the order of one
rotavirus infection per susceptible child-year at risk, increasing the prevalence of the “high-
risk” subgroup (α) from 0% 50% reduced the estimate of protection against RVGE conferred
Fig 3. Sources of bias in estimates of naturally-acquired immune protection. We compare “naïve” estimates of naturally-acquired
immunity (N^E ) against re-infection (A), against RVGE incidence (B), and against RVGE given re-infection (C) following one (grey),
two (red), or three (blue) previous infections in simulated cohorts. We parameterize the natural history model with estimates of natural
protection against re-infection (ψ), age-specific risk of RVGE given infection (β), and excess infection and RVGE risk within the “high-
risk” subgroup (ϕ, ρ) from Model 1 (Table 1, Fig 2). We vary the force of infection (Λ, measured as infections per susceptible person-
year-at-risk) and the proportion of children assumed to belong to the “high-risk” subgroup (α). Consistent with primary analyses of the
cohort data, simulated (“naïve”) analyses do not account for age-dependent RVGE risk. The plotted values can be interpreted as
predictions of estimated natural immunity against rotavirus infection, RVGE, and RVGE given infection, across sites with differing
force of infection (x-axes) or prevalence of high-risk individuals (panels left to right). We plot estimates from the original cohort
datasets within the left panels of each row (circles, with 95% confidence intervals), revealing that the higher force of infection and
prevalence of “high-risk” individuals in Vellore can explain some, although not all, of the difference in estimates of immune protection
between the Vellore and Mexico City cohorts.
https://doi.org/10.1371/journal.pcbi.1007014.g003
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by one previous infection by 9% (–12% to 27%), in absolute terms. Increasing transmission
intensity to the equivalent of four infections per susceptible child-year at risk led to a reduction
of 14% (–8% to 34%) at α = 0 and, similarly, of 12% (–6% to 27%) at α = 0.5, in absolute terms.
Discussion
Evidence of naturally-acquired immunity against rotavirus from birth-cohort studies provided
an impetus toward the development of live oral rotavirus vaccines, which are now among the
most effective strategies for the prevention of severe illness and deaths due to RVGE globally
[46]. However, challenges have persisted in understanding and addressing the lower protective
efficacy of rotavirus vaccines in high-burden LMIC settings, which mirrors protection derived
from naturally-acquired immunity [47,48]. Our analysis suggests that discrepant estimates of
protection may in part reflect epidemiological bias, attributable to differences between settings
in transmission intensity and differential susceptibility of children to rotavirus infection and
RVGE, individually and by age. Lower estimates of protection in settings with high rotavirus
burden thus reflect factors other than weaker immunity among children in LMICs.
Accounting for aspects of the natural history of rotavirus enabled us to directly compare
the susceptibility of children enrolled in birth cohort studies undertaken in socioeconomi-
cally-distinct settings. Although we estimated only modestly higher susceptibility for the aver-
age child in Vellore as compared to Mexico City, individual variation in susceptibility was
considerably greater within the Vellore cohort. We estimated that a higher proportion of chil-
dren in Vellore, as compared to Mexico City, showed elevated rates of rotavirus infection as
well as excess risk for RVGE given infection. This finding can account for several unexpected
features of the epidemiology of rotavirus in Vellore. The increasing probability of RVGE in
association with first, second, and later infections occurring at matched ages that we identified,
particularly in Vellore (Fig 1F), reflects high risk for RVGE given infection among individuals
susceptible to frequent rotavirus infection. In other words, children who experienced two or
more infections before 6 months of age, or three or more infections before 12 months of age,
are more likely to belong to a subgroup with pronounced susceptibility to rotavirus infection
and disease, given infection. Indeed, our analysis identified that susceptibility to rotavirus
infection was positively associated with susceptibility to RVGE given infection among individ-
ual children (S1 Table, S2 Fig). While the proportion of children belonging to a “high-risk”
subgroup constituted a source of epidemiologic bias in simulation studies, and was expected to
lead to estimates of weaker protection against RVGE in settings with higher transmission
intensity such as Vellore, the degree of bias imposed was not large.
Several other studies have recently addressed transmission-dynamic factors that may con-
tribute to the apparent underperformance of rotavirus vaccination in high-transmission set-
tings [32]. Using data from the PROVIDE trial of monovalent rotavirus vaccine in Bangladesh,
Rogawski and colleagues demonstrated that acquisition of naturally-acquired immunity may
contribute to lower estimates of vaccine efficacy due to earlier and more frequent infection
within the control arm; impacts on estimates of protection are most notable in high-transmis-
sion settings, and among children in their second year of life [15]. Here we were able to
account for the contribution of all previous infections to naturally-acquired immunity, includ-
ing subclinical infections, and to account for age-specific RVGE risk. Selection bias resulting
from variation in individual susceptibility can result in further downward bias [31], underscor-
ing the need for per-exposure estimates of immune effectiveness such as we have sought in this
analysis. Directly comparing susceptibility between populations or settings is difficult because
determinants of susceptibility are often unknown or unmeasured, and may be imperfectly
characterized by measurable epidemiological risk factors. The contributions of susceptibility
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and transmission intensity to disease incidence rates are not easily disentangled. Our analysis
employed a novel approach to characterize susceptibility of children in two cohorts based on a
model that included known aspects of rotavirus natural history, facilitated by access to similar
measurements from settings with distinct risk profiles and force of infection.
Our estimates of susceptibility appear externally valid based on their association with previ-
ously-reported risk factors for RVGE [49–52]: male children, children with lower birth weight,
and children whose mothers had lower educational attainment were more likely to belong to a
higher-risk subset of the population in our analysis. In Vellore, children whose households
were involved in bidi work—a marker for lower socioeconomic status—were also at higher
risk [36], while in Mexico City, we observed a trend toward lower risk associated with longer
breastfeeding, consistent with previous studies [53,54]. In addition, we observed higher inci-
dence of diarrhea caused by pathogens other than rotavirus among children who were found
to have greater susceptibility to rotavirus. This observation may signify the presence of envi-
ronmental enteric dysfunction within the cohorts, or other sources of variation in immune sta-
tus or pathogen exposure. In Vellore, children who we estimated were more susceptible to
rotavirus also experienced higher incidence of respiratory infections, as reported previously
[36]. While the associations we identify (in particular with time- or age-specific risk factors)
do not measure causal effects in either direction, our inferences pertaining to within-cohort
susceptibility are supported by the fact that children classified by the model as having “high
risk” exhibit risk factors widely believed to be associated with rotavirus infection and RVGE.
These and other host factors associated with susceptibility to rotavirus infection and RVGE
have also been reported to predict weaker immune responses to live enteric vaccines such as
those against rotavirus. While our model does not address variation in the strength of immune
responses among individuals or across settings, 58% of Indian children versus 90% of Mexican
children seroconverted after Rotarix immunization in previous studies [47,55]. Nonetheless,
near-equal naturally-acquired protection against re-infection was noted among children in the
birth cohort studies in Vellore and Mexico City. Our findings demonstrate that some degree
of the reported variation in protection against RVGE can be attributed to epidemiological
biases resulting from differential transmission intensity and differential susceptibility of chil-
dren, although we found age-dependent diarrhea risk was a more important contributor to
variation in estimates.
The finding that older age diminishes risk for children to experience RVGE given rotavirus
infection has been suggested in previous analyses of the cohort datasets [33]. Our simulation
study demonstrates that such age-related symptom risk enhances protection against RVGE in
low-transmission settings. Deferring infections to later ages significantly reduces the risk for
children to experience symptoms upon reinfection. While the mechanisms underlying age-
dependent diarrhea risk are not precisely known, the observation has been reported in mouse,
rat, rabbit, and gnotobiotic piglet models of rotavirus infection [56–59]. Age-dependent TLR3
expression and host responses to rotavirus enterotoxins contribute to this observation in mice
[60,61]. Other aspects of immune maturation, intestinal development, and the establishment
of gut microbial communities may further drive associations between age and diarrhea risk in
both humans and animals [62]. Furthermore, the greater dehydrating effect of diarrhea in
younger children with smaller body volumes may contribute to severity—and thus the report-
ing and diagnosis—of RVGE in early-life infections [63].
There are several limitations to our analysis. Whereas we assume exponentially-distributed
infection times (consistent with a constant hazard of infection), this provides an imperfect fit
to the timing of early-life infections, particularly in the Mexico City cohort. The departure
between predictions and observations may reflect the protective effect of maternal antibodies,
as reported previously [35,64], or the influence of age-specific social mixing patterns on
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transmission [65]. Thus, our model tended to overestimate the probability of RVGE associated
with second rotavirus infections in Mexico City, although this discrepancy was not sustained
for third and fourth infections. Our analyses also do not distinguish between homotypic and
heterotypic protection because we lack genotype data for serologically-detected infections,
which constitute the majority of infections in both cohorts. Although moderate-to-severe
RVGE episodes are the primary endpoint of most studies evaluating vaccine efficacy and effec-
tiveness, our analysis addressed RVGE episodes of any severity. Only 7% of children in Mexico
City experienced RVGE episodes with Vesikari score�11, limiting the statistical power for
analyses of moderate-to-severe RVGE. Nonetheless, previous analyses of the studies identified
similar risk factors for mild and moderate-to-severe RVGE [33]; moreover, we find that chil-
dren identified by our method to face higher risk for rotavirus infection and RVGE likewise
experienced higher risk for moderate-to-severe manifestations of RVGE episodes. Thus, our
findings may inform the interpretation of studies with moderate-to-severe RVGE endpoints.
Our ability to account for variation in susceptibility to infection as well as disease, and
indeed to identify a linkage between these traits, is a unique advantage afforded by data
describing both clinically-apparent and subclinical infections. While methods exist to account
for frailty in time-to-event data [10,66], as may be present in studies with only one class of end-
points (such as serological studies of infection or clinical trials with disease endpoints), suscep-
tibility to disease given infection is also of interest. Importantly, our findings suggest that age,
rather than naturally-acquired immunity, determines risk for rotavirus infections to present
symptomatically, together with individual-level susceptibility factors. Adaptations of our
model to the natural history of other pathogens may facilitate similar studies in other disease-
specific contexts. Whereas other models have used continuous distributions to characterize
individual susceptibility, this approach has generally relied on the ability to measure or even
manipulate exposure intensity at the individual level, for instance by measuring infectious con-
tacts or through controlled-dose challenge experiments [20–30]. As our data presented the
opportunity to compare exposure intensity between cohorts but not between individuals, we
considered a simpler case of dichotomous risk groups within cohorts, and determined how the
sizes of cohort-specific risk strata (α) were jointly distributed with the degree of risk elevation
(ϕ,ρ). A priori knowledge of risk strata, for instance based on previous estimates of covariate
effect sizes, presents an alternative strategy to infer distributions of individual-level susceptibil-
ity [67].
Birth-cohort studies have been instrumental to our understanding of the natural history of
rotavirus. Uncertainties surrounding differences in the epidemiology of rotavirus in socioeco-
nomically-distinct populations underscore the need for a theoretical basis for comparing out-
comes of individual studies. Our approach permitted assessment of how age, acquired
immunity, and variation in individual susceptibility independently contributed to infection
and disease risk in distinct birth cohorts, helping to resolve discrepancies in estimated protec-
tion that arose in primary analyses of the datasets. The modeling framework we introduce here
may thus have applicability to studies of other partially-immunizing pathogens.
Materials and methods
Birth cohort data
The two birth cohort studies followed similar protocols that have been described previously
[35,36]. Children were enrolled at birth and followed to 24 and 36 months of age in Mexico
City and Vellore, respectively. The studies aimed to detect all rotavirus infections, both symp-
tomatic and asymptomatic. Rotavirus infections were detected by three approaches: (1) sera
were drawn every 4 and 6 months in Mexico City and Vellore, respectively, and tested for IgA
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or IgG titer increases; (2) asymptomatic stool samples were collected weekly in Mexico City
and every two weeks in Vellore and tested for rotavirus; and (3) diarrheal stools were collected
by field workers every time mothers alerted the study teams of any change in a child’s stool
pattern (S2 Table). Virus detection was performed by ELISA in Mexico City and by ELISA or
real-time PCR in Vellore. In Mexico City, 200 children were recruited and retained for 77% of
the scheduled follow-up period, while our analysis of the Vellore dataset included the 373 chil-
dren (83% of 452 enrolled) who completed follow-up. Data were available for 96% (1037/1080)
and 99% (2565/2598) of scheduled serum tests; 97% (15,503/16,029) and 93% (26,902/28,906)
of scheduled asymptomatic stool tests; and 85% (963/1133) and 99% (1829/1856) of reported
diarrheal episodes in Mexico City and Vellore, respectively.
Modeling rotavirus natural history
Summary. We developed a probabilistic model describing rotavirus natural history that
allowed us to test how susceptibility to rotavirus infection and RVGE vary innately among
individuals and according to age and previous infection. Seeking to account for differences in
rotavirus epidemiology in the two settings under a unified model, we assumed parameters
reflecting the strength of immune protection and the effect of age on the probability of symp-
toms given infection were equal in both settings, whereas we permitted the force of infection
and the proportion of children belonging to distinct risk strata to vary between settings. We
compared the improvement in fit afforded by modifications reflecting distinct hypotheses
about the acquisition of protection against symptoms given infection—a source of uncertainty
in rotavirus epidemiology [33]. Individual-level susceptibility of children to infection and
RVGE was measured from the probability for children to belong to the high-risk stratum,
which we also tested for associations with epidemiological risk factors. Last, we simulated from
the fitted model to explore how differences in transmission intensity and the prevalence of
high-risk individuals influence estimates of protection.
Model. We developed a model for time-to-event data that included asymptomatic and
symptomatic rotavirus infection endpoints. Event time distributions were modeled from esti-
mates of the force of infection and from rotavirus natural history parameters modifying the
rate at which individuals acquired and re-acquired rotavirus infection, as well as the probabil-
ity of experiencing RVGE given infection. Observations from previous analyses of the cohort
studies suggested individuals differ in their susceptibility: in Vellore, children who experienced
diarrhea on second and later rotavirus infections were more likely to have experienced diar-
rhea on earlier-life infections [33]. We therefore accounted for potential variation in risk
among children by defining proportions αV and αM of children in Vellore and Mexico City,
respectively, belonging to a distinct risk group R, and tested for group-wise differences in sus-
ceptibility to rotavirus infection and RVGE in the R stratum relative to the remaining popula-
tion (Rc, with prevalence 1–αs in setting s). We defined the R stratum as whichever sub-group
occupied�50% of the Mexico City cohort, and thus, 0�αM�0.5 and 0�αV�1; the designation
of the R stratum as lower- or higher-risk depended upon estimates of the relative susceptibility
of children to infection and disease (ϕ and ρ, respectively; Table 1), the inverse of which would
apply for the remaining children. In a supplemental analysis (S1 Text), we considered the pos-
sibility of additional risk strata, which included all pairwise combinations of modified suscepti-
bility to infection and/or modified susceptibility to RVGE given infection.
Whereas primary analyses of the cohort datasets identified decreasing RVGE incidence
rates following previous rotavirus infection, re-analyses suggested this declining risk resulted
from naturally-acquired protection against rotavirus infection and older age at time of reinfec-
tion [33]. We used the Akaike Information Criterion (AIC) [44] to compare the fit of
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alternative, nested models premised on differing assumptions about the influence of age and
naturally-acquired immunity on risk of experiencing diarrhea symptoms during rotavirus
infection. Model 1 assumed the risk of RVGE given infection did not vary based on the num-
ber of previous infections. Model 2 considered both age and previous infection as determi-
nants of risk for RVGE given infection. We also attempted to fit a third model assuming that
only children in the RC (effectively, lower-risk) group acquired protection against symptoms
given infection, but found that parameters were not identifiable; thus, only Models 1 and 2
were considered.
We modeled infection at the rate lRc;s;k ¼ LsckIk among children in the majority (R
c) risk
group, where Λs was the force of infection in Mexico City or Vellore, Ik was an indicator that
an individual had experienced k previous rotavirus infections, and ψk was the hazard ratio for
reinfection resulting from naturally-acquired immune protection following k previous infec-
tions. Among children in the minority (R) risk group, we modeled lR;s;k ¼ �lRc ;s;k, where the
hazard ratio ϕ conveyed the effect of differential susceptibility to infection.
The probability of RVGE given rotavirus infection, π, was modeled as a function of age and
risk group under Model 1. For children of age x in the majority risk group,
p
ð1Þ
Rc ðxÞ ¼ expðb0 þ b1xþ b2x
2Þ; ð1Þ
where the parameters β0–2 related RVGE risk to the child’s age. Linear, exponential, and
higher-order polynomial functions relating risk to age were explored, but found not to
improve model fit via AIC. For the remaining children,
p
ð1Þ
R ðxÞ ¼ r expðb0 þ b1xþ b2x
2Þ; ð2Þ
where the relative risk ρ accounted for innate differences in susceptibility to RVGE given
infection.
Under Models 2 and 3, we further accounted for variation in symptom risk according to
the number of previous infections a child in the Rc stratum has experienced, such that for
Model 2,
p
ð2Þ
RCkðxÞ ¼ expðb0 þ b1xþ b2x
2ÞokIk;
p
ð2Þ
Rk ðxÞ ¼ r expðb0 þ b1xþ b2x2ÞokIk;
ð3Þ
where ωk indicated the fold change in risk of RVGE given infection after having experienced k
previous infections. For Model 3,
p
ð3Þ
Rc;kðxÞ ¼ expðb0 þ b1xþ b2x
2ÞokIk; ð4AÞ
whereas
p
ð3Þ
R;kðxÞ ¼ r expðb0 þ b1xþ b2x
2Þ ð4BÞ
for all k.
Likelihood. We estimated model parameters in a likelihood-based framework. Observa-
tions included all infections or instances of censoring (indexed by j) for each child (indexed by
i). For the jth observation of the ith child, we denoted time since the last observation or birth
as Δtij, indicating whether the child was currently infected with rotavirus with the variable Zij
(= 1 if infected and 0 if censoring occurred) and experiencing RVGE with the variable Dij (= 1
if RVGE occurred upon infection and 0 otherwise). The likelihood contribution of observation
j from child i, conditioned on the child belonging to either the R or Rc subgroup (�) and
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residing in setting s, was
Lði; jj�; sÞ ¼ f ðDtijjl�skjÞ½p�kjðxijÞDij þ ð1   p�kjðxijÞÞð1   DijÞ�Zij þ ½1   FðDtijjl�skjÞ�ð1
  ZijÞ: ð5Þ
The term f ðDtijjl�skjÞ represents the probability that the time to infection for individual i
was Δtij, while 1   FðDtijjl�skjÞ was the probability for child i to have escaped infection from
the time of the previous observation to the last follow-up visit, if censoring occurred at the jth
observation. We assumed an exponentially-distributed time to infection for inference, consis-
tent with an assumption of independent time-to-event observations given the child’s exposure,
infection history, and susceptibility status.
We obtained the likelihood contribution of each child, Hs(i), via the total probability
HsðiÞ ¼ as
Q
jLði; jjR; sÞ þ ð1   asÞ
Q
jLði; jjR
c; sÞ: ð6Þ
Defining Yi as the set of observations from each child i, the probability for any particular
child to be in the R risk group was
P RjYi; sð Þ ¼
PðR \ YijsÞ
PðYijsÞ
¼
asPðYijR; sÞ
asPðYijR; sÞ þ ð1   asÞPðYijR
c; sÞ
¼
as
Q
jLði; jjR; sÞ
as
Q
jLði; jjR; sÞ þ ð1   asÞ
Q
jLði; jjR
c; sÞ
: ð7Þ
Our statistical framework assumed that children were sampled at random from the popula-
tion and that observations Yi were randomly-assigned given the setting, age, risk group, and
infection history of an individual child i, such that the sample proportion of children in the R
group was expected to converge to the population proportion.
We thus defined the overall model likelihood in two components. The first, Gs
1
¼
Q
iHsðiÞ,
conveyed the direct contributions of exponentially-distributed time-to-event observations Yi
as described above. The second component, Gs
2
, reflected concordance between the population
proportion, αs, and the sample proportion, 1N
P
iPðRjYi; sÞ of children in the R risk group. We
calculated Gs
2
by evaluating the probability density of αs under the assumption of random
assignment:
as � Betaf
P
iPðRjYi; sÞ;
P
i½1   PðRjYi; sÞ�g: ð8Þ
Altogether, the model likelihood was the product of these terms across the two settings,
GM
1
GV
1
GM
2
GV
2
.
Estimation. Estimated between-group differences in susceptibility to infection and dis-
ease (ϕ and ρ, respectively) were dependent upon the size of the underlying proportions αM
and αV. For efficiency, we used a kernel-based inference approach whereby we reconstructed
the global distribution of parameters from their conditional distributions θ = {ϕ, ρ, ψ1−3, ω1−3,
β0−2, ΛM, ΛV} given fixed values of {αM, αV}, defined “locally” for αM = 0, 0.01, . . ., 0.5, and αV
= 0, 0.01, . . ., 1, respectively. For each set {αM, αV}, we determined the conditional maximum
likelihood parameter estimates θ�|αM,αV via the Nelder-Mead algorithm, using the optim()
function in R:
y
�
jaM; aV ¼ argminyjaM ;aVð  lnðG
M
1
GV
1
GM
2
GV
2
ÞÞ: ð9Þ
We assumed local parameter distributions at each set {αM, αV} were multivariate-normal,
with means defined by the conditional maximum likelihood estimates, and the asymptotic
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covariance matrix defined from the inverse of the negative Hessian, as evaluated by minimiz-
ing the negative log likelihood. We pooled draws from these conditional (local) multivariate
normal kernels over all {αM, αV}, weighting by their respective likelihoods, to recover the
unconditional (global) parameter distributions.
Independent estimation of ϕ and ρ, conditional on {αM, αV}, further enabled us to test the
hypothesis of a linkage between susceptibility to infection and disease, as suggested by the find-
ing of higher diarrhea risk among children experiencing high rates of re-infection (Fig 1E and
1F) and previously-reported associations [33]. Estimation of these parameters allows us dis-
criminate among hypotheses about susceptibility to infection and disease within the cohorts:
1. That there is no variation in susceptibility to infection or disease (ϕ = 1 and ρ = 1);
2. That excess/diminished susceptibility to infection has no linkage to disease risk (ϕ6¼1 and ρ
= 1), or that excess/diminished susceptibility to disease has no linkage to infection risk
(ρ6¼1 and ϕ = 1);
3. That susceptibility to infection and disease are inversely correlated (ρ>1 and ϕ<1, or ρ<1
and ϕ>1); or
4. That susceptibility to infection and disease are, in fact, correlated (ρ>1 and ϕ>1, or ρ<1
and ϕ<1).
We measured the probability of a linkage between these traits, as suggested under Hypothe-
sis 4, as
Prðr > 1j� > 1ÞPrð� > 1Þ þ Prðr < 1j� < 1ÞPrð� < 1Þ: ð10Þ
Supplemental analysis. We verified parameter estimates from this kernel-based approach
in an additional analysis, wherein we sampled from the distribution of parameter estimates via
Markov chain Monte Carlo using a Metropolis-Hastings updating procedure. Under this
approach, we were able to explore an exhaustive set of risk strata wherein susceptibility to
infection and to RVGE given infection could be linked or unlinked. This approach yielded
near-identical parameter estimates and inferences in comparison to the original kernel-based
approach, as we detail in the supporting files (S1 Text, S1 Table, S1 Fig, S2 Fig and S3 Fig);
the size of the risk groups not considered in the original analysis converged to zero. We identi-
fied strong evidence against the null hypothesis of unlinked susceptibility to infection and dis-
ease, with posterior probability for the null hypothesis less than 6.7×10−6.
Determinants of individual risk
To better understand variation in susceptibility among children within each cohort, we evalu-
ated associations between individual-level factors (Table 2) and the probability for each child
to belong to the high-risk (R) subgroup. For each of 10,000 draws of θ, we measured the proba-
bility of belonging to the high-risk group, equal to P(R|Yi,s) for ρ>1 or 1−P(R|Yi,s) for ρ<1,
for each child (in all samples, we identified ϕ>1 for ρ>1 and ϕ<1 for ρ<1). We used least-
squares regression to test for associations between covariates and children’s log-transformed
probability of being in the high-risk group, using estimated regression parameters to measure
relative risks (Table 3). Models included a setting term to account for differential prevalence
of high-risk children. We pooled relative risk estimates across our draws of θ to recover their
distribution.
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Simulation study
To examine potential bias in conventional estimates of naturally-acquired immune protection,
we used our model of the natural history of rotavirus infection to simulate individual histories
of infection and RVGE over the first three years of life, sampling from estimated parameters
describing the effects of age (β0, β1, β2) and previous infection (ψ1, ψ2, ψ3) on susceptibility to
RVGE and infection, respectively. We conducted simulations under an external force of infec-
tion (Λ) ranging from 0.2 to 4 infections per year, assigning 0% to 50% (α) of children to the
high-risk subgroup R; values of ϕ and ρ were drawn independently of α so that we could deter-
mine the effect of differences in the proportion of high-risk children on estimates of protec-
tion. We sampled exponentially-distributed infection times (calculated from time of birth or
previous infection), and defined the occurrence of RVGE for each individual infection as a
Bernoulli random variable using the model-predicted probability of RVGE given infection.
For each cohort simulation, we measured the hazard ratio for reinfection and RVGE from
the incidence rate (IRk) of infection and RVGE after one, two, or three previous infections, rel-
ative to the IR0 from birth. We also measured the relative risk of RVGE given reinfection
among children who had experienced one, two, or three previous infections, relative to those
with no previous infections, calculated from the proportion (pk) of infections with RVGE. We
defined estimates of natural immune efficacy (cNE) as
cNEk ¼ 1  
IRk
IR0
ð11Þ
for protection against infection and RVGE among children who had experienced k previous
infections, and
cNEk ¼ 1  
pk
p0
ð12Þ
for risk of RVGE given infection among children who had experienced k previous infections.
Supporting information
S1 Fig. Consistency of parameter estimates under the original and MCMC inference
approaches (1 of 2). We illustrate parameter estimates under the original kernel-based
approach (histograms) and from each of the 10 Markov chain Monte Carlo chains, overlaying
their probability densities and presenting thinned draws from the parameter trace plots over
150,000 iterations (after 50,000 burn-in iterations). Parameters include: (A) hazard ratios for
infection ψ1,ψ2, and ψ3; (B and C) setting-specific force of infection for Vellore and Mexico
City; and (D, E, and F) the polynomial terms describing age-specific diarrhea risk, given infec-
tion.
(TIF)
S2 Fig. Consistency of parameter estimates under the original and MCMC inference
approaches (2 of 2). We illustrate parameter estimates and their joint distributions under the
original kernel-based approach (histograms) and from each of the 10 Markov chain Monte
Carlo chains (colored lines, as indicated in S1 Fig), overlaying their probability densities and
presenting thinned draws from the parameter trace plots over 150,000 iterations (after 50,000
burn-in iterations). Parameters include (A) hazard ratio for infection ϕ, (B) relative risk of
RVGE given infection ρ, (C) prevalence of the baseline risk group in Mexico City a00M , and (D)
Vellore a00V . (E) We plot samples from the joint distribution of a
11
M and a
11
V , revealing concor-
dance with the original estimates of the joint distribution of αM and αV plotted in Fig 2D. We
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also illustrate concordance in samples from the joint distribution of the following parameters
under the two approaches: (F) a11M and ϕ; (G) a
11
V and ϕ; (H) a
11
M and ρ; and (I) a
11
V and ρ.
(TIF)
S3 Fig. MCMC samples for risk groups. We present samples of the proportion of individuals
belonging to the various risk groups from each of the 10 Markov chain Monte Carlo chains,
overlaying their posterior distributions and presenting thinned draws from the parameter trace
plots over 150,000 iterations (after 50,000 burn-in iterations). The first panels indicate the pro-
portion of individuals belonging to the risk group with modified rates of acquiring infection
(i.e., for whom ϕ applies) in (A) Vellore and (B) Mexico City, while the next two panels (C and
D) illustrate the proportion of these individuals with modified risk of diarrhea given infection
(i.e., for whom ρ applies). Among the proportion without modified rates of acquiring infection
(i.e., for whom ϕ does not apply), the proportion who also do not experience modified risk of
diarrhea given infection (i.e., for whom ρ does not apply) is illustrated in the final two panels (E
and F). Convergence of the parameters a01M ; a
01
V ; a
10
M , and a
10
V to zero (see S3 Table) results in the
concentration of probability mass very close to one across all chains (panels C–F).
(TIF)
S1 Table. Testing for linkages in susceptibility to infection and disease under Markov
Chain Monte Carlo sampling. We present parameter estimates and their 95% credible inter-
vals under the model including strata with distinct susceptibility to infection and disease
(either or in combination), as well as posterior probabilities for hypothesis tests.
(DOCX)
S2 Table. Study design, enrollment, and follow-up. 1Sample restricted to children who com-
pleted 3 years of follow-up (83% of initial cohort of 452 children) 2The total number was not
provided in the original study, but was calculated from the information that the 963 tested epi-
sodes represented 85% of the total reported episodes. 2In the Mexico City cohort, the mean age
of asymptomatic infections detected by shedding is lower than the mean age of asymptomatic
infections detected by seroconversion alone (p<0.0001). 3In the Vellore cohort, the mean age
of asymptomatic infections detected by shedding is lower than the mean age of asymptomatic
infections detected by seroconversion alone (p<0.001).
(DOCX)
S3 Table. Primary estimates of naturally-acquired immune protection. 1Incidence is mea-
sured per 100 child-months at risk 2The original studies applied differing definitions for mod-
erate-to-severe RVGE; here we consider episodes with Vesikari score�11 to constitute
moderate-to-severe RVGE.
(DOCX)
S1 Text. Supplemental materials. Text including supplemental methods, tables, and figures.
(PDF)
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